MedPath

The Effectiveness of Multimodal Educational Intervention to Improve Adherence to Treatment Regimens in Older Stroke Patients

Not Applicable
Conditions
Medication Adherence
Stroke
Older Adults
Registration Number
NCT02842840
Lead Sponsor
Qazvin University Of Medical Sciences
Brief Summary

Stroke is a major cause of morbidity and mortality, especially in low and middle income countries including Iran. Patients with recent stroke or TIA are at high risk for new vascular events. Several evidence based strategies in secondary prevention of stroke are available but frequently underused. The study is aimed to evaluate an intervention to improve patients with Stroke.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
405
Inclusion Criteria
  • aged 65 years or older
  • able to give informed consent
Exclusion Criteria
  • recurrent stroke
  • a diagnosis of subarachnoid haemorrhage
  • significant impairments precluding participation - inability to give informed consent
  • another condition likely to impact their participation in the trial (e.g. life-threatening condition other than cardiovascular disease)
  • expected discharge to hospital/nursing home setting

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
changes in low-density lipoprotein (LDL)-cholesterol levelchanges from baseline, 6 Months, 12 months and 18 months follow-up
changes in Patient-reported Adherence Medication Adherence Rating Scalechanges from baseline, 6 Months, 12 months and 18 months follow-up

a self-report measure of adherence (Medication Adherence Report Scale \[MARS-5\]) will be used .

changes in blood pressurechanges from baseline, 6 Months, 12 months and 18 months follow-up
Secondary Outcome Measures
NameTimeMethod
Changes in intention to medication adherencechanges from baseline, 6 Months, 12 months and 18 months follow-up
Changes in Action Planchanges from baseline, 6 Months, 12 months and 18 months follow-up

The action plan is assessed by a self-reported questionnaire. it is used by the patients before, at baseline, six months, twelve months and eighteen months after the intervention

Changes in Coping Planchanges from baseline, 6 Months, 12 months and 18 months follow-up

The coping plan is assessed by a self-reported questionnaire. It is used by the patients before, at baseline, six months, twelve months and eighteen months after the intervention

Changes in quality of lifechanges from baseline, 6 Months, 12 months and 18 months follow-up

The Short Form (36) Health Survey is used to assess patient's quality of life

Changes in perceived behavioral control to medication adherencechanges from baseline, 6 Months, 12 months and 18 months follow-up

The perceived behavioral control to medication adherence is assessed through a self-report instrument

Changes in Self-monitoring to medication adherencechanges from baseline, 6 Months, 12 months and 18 months follow-up

The Self-monitoring to medication adherence is assessed through a self-report instrument

Changes in Illness Perceptionschanges from baseline, 6 Months, 12 months and 18 months follow-up

the Brief Illness Perception. Questionnaire (Brief IPQ) is used to assess patient's illness representation

Trial Locations

Locations (3)

Department of Public Health, Qazvin University of Medical Sciences

🇮🇷

Qazvin, Iran, Islamic Republic of

Qazvin University of Medical Sciences

🇮🇷

Qazvin, Iran, Islamic Republic of

Outpatient Pediatric Clinic

🇮🇷

Qazvin, Iran, Islamic Republic of

Department of Public Health, Qazvin University of Medical Sciences
🇮🇷Qazvin, Iran, Islamic Republic of
Amir Pakpour, Ph.D.
Contact
982813338127
amir.pakpour@gmail.com
Amir H Pakpour, Ph.D.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.